Cargando…

Assessment of Phage-Mediated Inhibition and Removal of Multidrug-Resistant Pseudomonas aeruginosa Biofilm on Medical Implants

PURPOSE: Despite the growing interest in bacteriophage (phage) usage for the prevention, control, and removal of bacterial biofilms, few scientific data exist on phage applications on medical implant surfaces, while none exists on multiple implants. In this study, we aimed to isolate, biophysically...

Descripción completa

Detalles Bibliográficos
Autores principales: Amankwah, Stephen, Adisu, Mekonen, Gorems, Kasahun, Abdella, Kedir, Kassa, Tesfaye
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9166914/
https://www.ncbi.nlm.nih.gov/pubmed/35668859
http://dx.doi.org/10.2147/IDR.S367460
_version_ 1784720714507485184
author Amankwah, Stephen
Adisu, Mekonen
Gorems, Kasahun
Abdella, Kedir
Kassa, Tesfaye
author_facet Amankwah, Stephen
Adisu, Mekonen
Gorems, Kasahun
Abdella, Kedir
Kassa, Tesfaye
author_sort Amankwah, Stephen
collection PubMed
description PURPOSE: Despite the growing interest in bacteriophage (phage) usage for the prevention, control, and removal of bacterial biofilms, few scientific data exist on phage applications on medical implant surfaces, while none exists on multiple implants. In this study, we aimed to isolate, biophysically characterize and assess phages as potential antibiofilm agents to inhibit and remove multidrug-resistant (MDR) Pseudomonas aeruginosa biofilm on catheter and endotracheal tube surfaces. METHODS: The well-identified stored clinical isolates (n = 7) of MDR P. aeruginosa were obtained from Jimma Medical Center. Specific phages were isolated and characterized based on standard protocols. The phages were tested for their antibiofilm effects in preventing colonization and removing preformed biofilms of MDR P. aeruginosa, following phage coating and treatment of catheter and endotracheal tube segments. RESULTS: Two P. aeruginosa-specific phages (ΦJHS-PA1139 and ΦSMK-PA1139) were isolated from JMC compound sewage sources. The phages were biophysically characterized as being thermally stable up to 40°C and viable between pH 4.0 and 11.0. The two phages tested against clinical MDR strains of P. aeruginosa showed broad host ranges but not on other tested bacterial species. Both phages reduced MDR bacterial biofilms during the screening step. The phage-coated segments showed 1.2 log(10) up to 3.2 log(10) inhibition relative to non-coated segments following 6 h coating of segments prior to microbial load exposure. In both phages, 6 h treatment of the segments with 10(6) PFU/mL yielded 1.0 log(10) up to 1.6 log(10) reductions for ΦJHS and 1.6 log(10) up to 2.4 log(10) reductions for ΦSMK. CONCLUSION: Our results suggest that phages have great potential to serve the dual purpose as surface coating agents for preventing MDR bacterial colonization in medical implants and as biofilm removal agents in implant-associated infections.
format Online
Article
Text
id pubmed-9166914
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-91669142022-06-05 Assessment of Phage-Mediated Inhibition and Removal of Multidrug-Resistant Pseudomonas aeruginosa Biofilm on Medical Implants Amankwah, Stephen Adisu, Mekonen Gorems, Kasahun Abdella, Kedir Kassa, Tesfaye Infect Drug Resist Original Research PURPOSE: Despite the growing interest in bacteriophage (phage) usage for the prevention, control, and removal of bacterial biofilms, few scientific data exist on phage applications on medical implant surfaces, while none exists on multiple implants. In this study, we aimed to isolate, biophysically characterize and assess phages as potential antibiofilm agents to inhibit and remove multidrug-resistant (MDR) Pseudomonas aeruginosa biofilm on catheter and endotracheal tube surfaces. METHODS: The well-identified stored clinical isolates (n = 7) of MDR P. aeruginosa were obtained from Jimma Medical Center. Specific phages were isolated and characterized based on standard protocols. The phages were tested for their antibiofilm effects in preventing colonization and removing preformed biofilms of MDR P. aeruginosa, following phage coating and treatment of catheter and endotracheal tube segments. RESULTS: Two P. aeruginosa-specific phages (ΦJHS-PA1139 and ΦSMK-PA1139) were isolated from JMC compound sewage sources. The phages were biophysically characterized as being thermally stable up to 40°C and viable between pH 4.0 and 11.0. The two phages tested against clinical MDR strains of P. aeruginosa showed broad host ranges but not on other tested bacterial species. Both phages reduced MDR bacterial biofilms during the screening step. The phage-coated segments showed 1.2 log(10) up to 3.2 log(10) inhibition relative to non-coated segments following 6 h coating of segments prior to microbial load exposure. In both phages, 6 h treatment of the segments with 10(6) PFU/mL yielded 1.0 log(10) up to 1.6 log(10) reductions for ΦJHS and 1.6 log(10) up to 2.4 log(10) reductions for ΦSMK. CONCLUSION: Our results suggest that phages have great potential to serve the dual purpose as surface coating agents for preventing MDR bacterial colonization in medical implants and as biofilm removal agents in implant-associated infections. Dove 2022-05-31 /pmc/articles/PMC9166914/ /pubmed/35668859 http://dx.doi.org/10.2147/IDR.S367460 Text en © 2022 Amankwah et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Amankwah, Stephen
Adisu, Mekonen
Gorems, Kasahun
Abdella, Kedir
Kassa, Tesfaye
Assessment of Phage-Mediated Inhibition and Removal of Multidrug-Resistant Pseudomonas aeruginosa Biofilm on Medical Implants
title Assessment of Phage-Mediated Inhibition and Removal of Multidrug-Resistant Pseudomonas aeruginosa Biofilm on Medical Implants
title_full Assessment of Phage-Mediated Inhibition and Removal of Multidrug-Resistant Pseudomonas aeruginosa Biofilm on Medical Implants
title_fullStr Assessment of Phage-Mediated Inhibition and Removal of Multidrug-Resistant Pseudomonas aeruginosa Biofilm on Medical Implants
title_full_unstemmed Assessment of Phage-Mediated Inhibition and Removal of Multidrug-Resistant Pseudomonas aeruginosa Biofilm on Medical Implants
title_short Assessment of Phage-Mediated Inhibition and Removal of Multidrug-Resistant Pseudomonas aeruginosa Biofilm on Medical Implants
title_sort assessment of phage-mediated inhibition and removal of multidrug-resistant pseudomonas aeruginosa biofilm on medical implants
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9166914/
https://www.ncbi.nlm.nih.gov/pubmed/35668859
http://dx.doi.org/10.2147/IDR.S367460
work_keys_str_mv AT amankwahstephen assessmentofphagemediatedinhibitionandremovalofmultidrugresistantpseudomonasaeruginosabiofilmonmedicalimplants
AT adisumekonen assessmentofphagemediatedinhibitionandremovalofmultidrugresistantpseudomonasaeruginosabiofilmonmedicalimplants
AT goremskasahun assessmentofphagemediatedinhibitionandremovalofmultidrugresistantpseudomonasaeruginosabiofilmonmedicalimplants
AT abdellakedir assessmentofphagemediatedinhibitionandremovalofmultidrugresistantpseudomonasaeruginosabiofilmonmedicalimplants
AT kassatesfaye assessmentofphagemediatedinhibitionandremovalofmultidrugresistantpseudomonasaeruginosabiofilmonmedicalimplants